
American Well (AMWL) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
66.8M
Gross Profit
35.3M
52.76%
Operating Income
-30.4M
-45.50%
Net Income
-18.4M
-27.47%
EPS (Diluted)
$-1.19
Balance Sheet Metrics
Total Assets
419.5M
Total Liabilities
113.7M
Shareholders Equity
305.8M
Debt to Equity
0.37
Cash Flow Metrics
Operating Cash Flow
-5.3M
Free Cash Flow
-25.1M
Revenue & Profitability Trend
American Well Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 254.4M | 259.0M | 277.2M | 252.8M | 245.3M |
Cost of Goods Sold | 155.4M | 164.3M | 160.4M | 148.5M | 156.8M |
Gross Profit | 99.0M | 94.8M | 116.8M | 104.3M | 88.5M |
Gross Margin % | 38.9% | 36.6% | 42.1% | 41.3% | 36.1% |
Operating Expenses | |||||
Research & Development | 86.1M | 105.8M | 138.5M | 106.6M | 84.4M |
Selling, General & Administrative | 197.4M | 213.1M | 228.0M | 160.8M | 221.3M |
Other Operating Expenses | - | - | - | - | - |
Total Operating Expenses | 283.5M | 318.9M | 366.5M | 267.4M | 305.8M |
Operating Income | -217.5M | -255.7M | -275.9M | -179.1M | -227.4M |
Operating Margin % | -85.5% | -98.7% | -99.5% | -70.9% | -92.7% |
Non-Operating Items | |||||
Interest Income | 10.8M | 19.4M | 6.1M | 120.0K | 1.6M |
Interest Expense | - | - | - | - | - |
Other Non-Operating Income | - | -436.5M | - | - | - |
Pre-tax Income | -206.8M | -672.7M | -269.7M | -179.0M | -225.8M |
Income Tax | 2.8M | 3.9M | 64.0K | -5.4M | 639.0K |
Effective Tax Rate % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Net Income | -212.6M | -679.2M | -272.1M | -176.8M | -228.6M |
Net Margin % | -83.6% | -262.2% | -98.2% | -69.9% | -93.2% |
Key Metrics | |||||
EBITDA | -184.6M | 212.3M | -249.7M | -163.1M | -217.3M |
EPS (Basic) | $-13.88 | $-47.60 | $-19.80 | $-13.80 | $-45.40 |
EPS (Diluted) | $-13.88 | $-47.60 | $-19.80 | $-13.80 | $-45.40 |
Basic Shares Outstanding | 14999590 | 14212837 | 13712487 | 12703447 | 4952215 |
Diluted Shares Outstanding | 14999590 | 14212837 | 13712487 | 12703447 | 4952215 |
Income Statement Trend
American Well Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 228.3M | 372.0M | 538.5M | 746.4M | 941.6M |
Short-term Investments | - | - | - | 0 | 100.0M |
Accounts Receivable | 71.9M | 54.1M | 58.4M | 51.4M | 45.3M |
Inventory | 2.9M | 6.7M | 8.7M | 7.5M | 9.1M |
Other Current Assets | 11.4M | 14.5M | 19.6M | 20.3M | - |
Total Current Assets | 317.0M | 449.6M | 626.6M | 827.3M | 1.1B |
Non-Current Assets | |||||
Property, Plant & Equipment | 7.2M | 10.5M | 13.5M | 16.4M | 6.6M |
Goodwill | 101.5M | 120.2M | 1.0B | 1.0B | 443.3M |
Intangible Assets | 101.5M | 120.2M | 135.0M | 152.4M | 55.5M |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 8.4M | 7.7M | 6.2M | 4.5M | 2.8M |
Total Non-Current Assets | 119.0M | 140.1M | 590.9M | 618.5M | 263.4M |
Total Assets | 436.0M | 589.7M | 1.2B | 1.4B | 1.4B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 5.0M | 4.9M | 7.2M | 12.2M | 5.8M |
Short-term Debt | 3.7M | 3.6M | 3.1M | 1.9M | 6.4M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 10.1M | 12.1M | 9.8M | 7.9M | 10.2M |
Total Current Liabilities | 111.3M | 93.8M | 114.1M | 141.6M | 121.0M |
Non-Current Liabilities | |||||
Long-term Debt | 4.5M | 8.2M | 11.8M | 14.7M | 1.3M |
Deferred Tax Liabilities | - | - | - | - | - |
Other Non-Current Liabilities | 1.2M | 1.4M | 1.6M | 21.6M | 64.0K |
Total Non-Current Liabilities | 8.5M | 15.7M | 19.6M | 43.3M | 9.5M |
Total Liabilities | 119.7M | 109.5M | 133.7M | 185.0M | 130.4M |
Equity | |||||
Common Stock | 156.0K | 2.9M | 2.8M | 2.6M | 2.4M |
Retained Earnings | -2.0B | -1.8B | -1.1B | -811.3M | -582.4M |
Treasury Stock | - | - | - | 0 | 37.6M |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 316.2M | 480.2M | 1.1B | 1.3B | 1.2B |
Key Metrics | |||||
Total Debt | 8.2M | 11.8M | 14.8M | 16.6M | 7.7M |
Working Capital | 205.7M | 355.8M | 512.6M | 685.7M | 992.3M |
Balance Sheet Composition
American Well Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | -212.6M | -679.2M | -272.1M | -176.8M | -228.6M |
Depreciation & Amortization | 33.0M | 31.5M | 26.2M | 16.1M | 10.2M |
Stock-Based Compensation | 47.5M | 72.2M | 67.7M | 43.8M | 118.4M |
Working Capital Changes | -22.7M | -5.1M | -36.9M | -21.6M | -25.3M |
Operating Cash Flow | -152.2M | -578.0M | -204.2M | -139.2M | -123.2M |
Investing Activities | |||||
Capital Expenditures | -119.0K | -192.0K | -292.0K | -559.0K | -3.3M |
Acquisitions | -3.4M | -3.9M | -2.0M | -159.1M | -2.9M |
Investment Purchases | 0 | -390.0M | -499.2M | 0 | -159.6M |
Investment Sales | 0 | 390.0M | 500.0M | 100.0M | 99.1M |
Investing Cash Flow | -3.5M | -4.1M | -1.5M | -59.6M | -66.8M |
Financing Activities | |||||
Share Repurchases | -3.0K | -586.0K | -360.0K | -15.0M | -37.6M |
Dividends Paid | - | - | - | - | - |
Debt Issuance | - | - | - | - | - |
Debt Repayment | - | - | - | - | - |
Financing Cash Flow | -3.0K | -586.0K | -11.9M | -16.7M | 977.2M |
Free Cash Flow | -142.6M | -163.6M | -202.8M | -142.1M | -115.8M |
Net Change in Cash | -155.7M | -582.7M | -217.5M | -215.5M | 787.2M |
Cash Flow Trend
American Well Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
-0.49
Forward P/E
-0.88
Price to Book
0.39
Price to Sales
0.40
PEG Ratio
0.01
Profitability Ratios
Profit Margin
-46.16%
Operating Margin
-28.74%
Return on Equity
-37.62%
Return on Assets
-17.93%
Financial Health
Current Ratio
3.30
Debt to Equity
2.17
Beta
1.28
Per Share Data
EPS (TTM)
$-8.03
Book Value per Share
$17.56
Revenue per Share
$17.38
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
amwl | 108.5M | -0.49 | 0.39 | -37.62% | -46.16% | 2.17 |
Veeva Systems | 44.1B | 55.52 | 6.66 | 13.70% | 27.29% | 1.29 |
Ge Healthcare | 34.6B | 14.83 | 3.40 | 25.80% | 11.22% | 107.67 |
Health Catalyst | 237.9M | -2.94 | 0.68 | -28.42% | -31.67% | 49.72 |
Sophia Genetics SA | 219.0M | -3.41 | 2.85 | -74.09% | -105.32% | 83.21 |
CareCloud | 148.1M | -12.48 | 2.60 | 22.69% | 10.08% | 6.04 |
Financial data is updated regularly. All figures are in the company's reporting currency.